What's in Ten Sun Pharma Company Limited's pipeline?

Ten Sun Pharma Company Limited has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Ten Sun Pharma Company Limited's portfolio?

Top competitors by shared drug class: Prince of Songkla University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ten-sun-pharma-company-limited.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Ten Sun Pharma Company Limited — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ten Sun Pharma Company Limited pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Esarin Gel	Esarin Gel	marketed	Topical protectant		Dermatology

Therapeutic area mix

Dermatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Prince of Songkla University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Ten Sun Pharma Company Limited:

Cite this brief

Drug Landscape (2026). Ten Sun Pharma Company Limited — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ten-sun-pharma-company-limited. Accessed 2026-05-17.